In-hospital cardiac arrest (IHCA) is a critical medical emergency characterised by the sudden cessation of cardiac function within a hospital setting. It's a harrowing event with significant implications for patient outcomes. Unlike out-of-hospital cardiac arrest, which often occurs in the community, IHCA transpires in healthcare facilities, where rapid response and effective intervention are crucial.

Causes can vary from underlying heart conditions to complications of severe illnesses or medical procedures. Prompt recognition, immediate cardiopulmonary resuscitation (CPR) initiation, and advanced life support measures are vital in improving survival rates and minimising neurological sequelae. Understanding the factors contributing to IHCA and implementing preventive strategies are paramount in enhancing patient safety within healthcare institutions.

Causes of In-Hospital Cardiac Arrest

In-hospital cardiac arrest (IHCA) can arise from multiple underlying conditions and precipitating factors within healthcare settings. Understanding these causes is crucial for implementing preventive measures and optimising patient care.

Underlying Cardiovascular Disease - Patients with pre-existing heart conditions such as myocardial infarction, coronary artery disease, or heart failure are at heightened risk of IHCA. Patients with these conditions are predisposed to sudden cardiac events and cardiac arrhythmias.
Respiratory Compromise - Respiratory failure, airway obstruction and inadequate oxygenation can lead to IHCA. Conditions such as chronic obstructive pulmonary disease (COPD), pneumonia, or acute respiratory distress syndrome (ARDS) may trigger and precipitate respiratory deterioration, leading to cardiac arrest.
Electrolyte Imbalance and Metabolic Disorders - Disturbances in metabolic abnormalities (e.g., acidosis, alkalosis) or electrolyte levels (e.g., potassium, magnesium) can disrupt cardiac rhythm and function, resulting in IHCA.
Medication Adverse Effects - Certain medications, such as sedatives, antiarrhythmics or opioids, may have cardiotoxic effects, contributing to IHCA risk.
Systemic Infections or Sepsis - Severe infections and sepsis can trigger systemic inflammatory responses, leading to cardiac dysfunction and haemodynamic instability, resulting in IHCA.
Surgical and Procedural Complications - Postoperative complications, peri-procedural events, or anaesthesia-related adverse reactions can precipitate IHCA, necessitating prompt recognition and intervention.

Understanding the diverse factors contributing to IHCA underscores the importance of vigilant monitoring, early detection of deterioration, and proactive management strategies to mitigate risks and improve patient outcomes within healthcare environments.

Treatment for In-House Cardiac Arrest

In-hospital cardiac arrest (IHCA) demands immediate and coordinated interventions to maximise the chances of patient survival and minimise neurological issues.

Early Recognition and Activation - Prompt identification of cardiac arrest symptoms, including loss of consciousness, absence of pulse, and agonal breathing, is critical. Healthcare providers must swing into emergency response immediately if IHCA is suspected.
High-Quality CPR - High-quality chest compressions and adequate ventilation form the cornerstone of IHCA management. Guidelines recommend maintaining a compression rate of 100-120 per minute and ensuring full chest recoil to optimise blood flow and oxygenation.
Defibrillation - Rapid defibrillation is essential for IHCA cases associated with shockable rhythms such as ventricular fibrillation or pulseless ventricular tachycardia. Automated external defibrillators (AEDs) or manual defibrillators should be promptly applied following CPR cycles.
Advanced Cardiac Life Support (ACLS) - Advanced interventions, including airway management, intravenous access, and administration of medications such as epinephrine and antiarrhythmics, are vital components of ACLS protocols. These measures aim to restore effective circulation and achieve a return of spontaneous circulation (ROSC).
Post-Resuscitation Care - Following ROSC, comprehensive post-resuscitation care is imperative to optimise neurological outcomes and prevent secondary complications. Hemodynamic optimisation, targeted temperature management, and monitoring for potential organ dysfunction are essential elements of post-arrest care protocols.

Timely and coordinated implementation of these treatment modalities is crucial in improving survival rates and reducing morbidity associated with IHCA episodes.

Prevention From In-House Cardiac Arrest

Preventing in-hospital cardiac arrest (IHCA) hinges on comprehensive strategies aimed at identifying and addressing modifiable risk factors, enhancing patient monitoring, and promoting a culture of safety within healthcare settings.

Early Detection and Monitoring - Implementing continuous cardiac monitoring and surveillance systems enables early detection of deteriorating patients, allowing for timely intervention before cardiac arrest occurs.
Rapid Response Systems (RRS) - Establishing RRS with clear escalation protocols facilitates prompt assessment and management of patients showing signs of clinical deterioration, reducing the likelihood of progression to cardiac arrest.
Optimising Care for High-Risk Patients - Tailoring care protocols for patients with known risk factors for IHCA, such as cardiovascular disease, respiratory compromise, or sepsis, can help mitigate risks and prevent adverse events.
Healthcare Provider Training - Regular training in basic life support (BLS), advanced cardiac life support (ACLS), and crisis resource management equips healthcare providers with the skills and confidence to manage cardiac emergencies and improve outcomes effectively.
Medication Safety Measures - Implementing medication reconciliation processes, vigilant monitoring, and standardised dosing protocols for medication adverse effects can minimise the risk of drug-related cardiac events leading to IHCA.

Conclusion

Preventing in-hospital cardiac arrest (IHCA) requires a multifaceted approach involving early detection, staff education, rapid response systems, and continuous quality improvement. By implementing comprehensive strategies to identify and mitigate risk factors, healthcare facilities can enhance patient safety and improve outcomes. Through vigilant monitoring, proactive intervention, and a culture of collaboration, IHCA occurrences can be minimised, underscoring the importance of prioritising preventive measures within healthcare settings.

Frequently Asked Questions

Q1. What are the primary risk factors for in-hospital cardiac arrest (IHCA)?
A1. Primary risk factors include underlying cardiovascular disease, respiratory compromise, electrolyte imbalances, medication adverse effects, and surgical/procedural complications.

Q2. What is the recommended compression rate during cardiopulmonary resuscitation (CPR) for IHCA patients?
A2. The recommended compression rate is between 100 to 120 compressions per minute to optimise blood flow and oxygenation.

Q3. How can healthcare providers improve the early detection of deteriorating patients to prevent IHCA?
A3. Implementing continuous monitoring systems and rapid response teams (RRTs) enables early detection and intervention for deteriorating patients.

Q4. What post-resuscitation care measures are essential for optimising outcomes following IHCA?
A4. Post-resuscitation care measures may include targeted temperature management, hemodynamic optimisation, and monitoring for organ dysfunction to prevent secondary complications.

Q5. How can healthcare institutions foster a culture of safety to prevent IHCA occurrences?
A5. Healthcare institutions can promote staff education, open communication, and quality improvement initiatives to enhance patient safety and reduce the incidence of IHCA through proactive measures.

References:

https://journals.lww.com/co-criticalcare/abstract/2023/06000/in_hospital_cardiac_arrest.7.aspx
https://pubmed.ncbi.nlm.nih.gov/30912843/
https://ccforum.biomedcentral.com/articles/10.1186/s13054-022-04247-y